Publication related to RSI or an RSI staff member

A simple data transformation for estimating benchmark doses in developmental toxicity experiments.

Authors

  • Krewski, D, Krewski D, Health Protection Branch, Health Canada, Ottawa, Ontario.

  • Zhu, Y, Zhu Y,

YEAR OF PUBLICATION: 1995
SOURCE: Risk Anal. 1995 Feb;15(1):29-39. doi: 10.1111/j.1539-6924.1995.tb00090.x.
JOURNAL TITLE ABBREVIATION: Risk Anal
JOURNAL TITLE: Risk analysis : an official publication of the Society for Risk Analysis
ISSN: 0272-4332 (Print) 0272-4332 (Linking)
VOLUME: 15
ISSUE: 1
PAGES: 29-39
PLACE OF PUBLICATION: United States
ABSTRACT:

Developmental anomalies induced by toxic chemicals may be identified using laboratory experiments with rats, mice or rabbits. Multinomial responses of fetuses from the same mother are often positively correlated, resulting in overdispersion relative to multinomial variation. In this article, a simple data transformation based on the concept of generalized design effects due to Rao-Scott is proposed for dose-response modeling of developmental toxicity. After scaling the original multinomial data using the average design effect, standard methods for analysis of uncorrelated multinomial data can be applied. Benchmark doses derived using this approach are comparable to those obtained using generalized estimating equations with an extended Dirichlet-trinomial covariance function to describe the dispersion of the original data. This empirical agreement, coupled with a large sample theoretical justification of the Rao-Scott transformation, confirms the applicability of the statistical methods proposed in this article for developmental toxicity risk assessment.

LANGUAGE: eng
DATE OF PUBLICATION: 1995 Feb
DATE COMPLETED: 19950602
DATE REVISED: 20191023
MESH DATE: 1995/02/01 00:01
EDAT: 1995/02/01 00:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski